Angeliki Panagiotara1, Theodora Katsila1,2, Minos-Timotheos Matsoukas2, George P Patrinos2 and Dimitrios Kardamakis1,3*
1Department of Radiobiology and Radiation Oncology, University of Patras Medical School, Greece
2Department of Pharmacy, University of Patras, Greece
3Department of Radiation Oncology, University of Patras Medical School, Greece
The newly-established view in cancer management is that “one size does not fit all”. Every tumour type is a molecularly unique and complex entity, due to inter- and intra-tumour heterogeneity, not only between patients, but in the same patient as well. Diagnostic and therapeutic strategies should be specifically tailored to each patient, however widely accepted criteria for patient stratification and individualizing treatment are still elusive. Undoubtedly, it is time for oncology to move from basic to translational clinical research and multi-omics strategies can pave the way towards this goal by employing a bench-to- bedside attitude.
Omics; Biomarkers; Precision Oncology
Panagiotara A, Katsila T, Matsoukas M-T, Patrinos GP, Kardamakis D. Precision Oncology: Bridging the Knowledge Gap with Multi-Omics. Jpn J Cancer Oncol Res. 2018; 1(1): 1003.